NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+8.51%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.11B
AUM Growth
+$1.11B
(+8.6%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
128
New
18
Increased
18
Reduced
46
Closed
17
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$107M |
| 2 |
Hilton Grand Vacations
HGV
|
$15.9M |
| 3 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$8.1M |
| 4 |
Bioventus
BVS
|
$7.28M |
| 5 |
Payoneer
PAYO
|
$4.94M |
Top Sells
| 1 |
Costco
COST
|
$40.9M |
| 2 |
Light & Wonder
LNW
|
$29.8M |
| 3 |
DXP Enterprises
DXPE
|
$22.7M |
| 4 |
MillerKnoll
MLKN
|
$11.8M |
| 5 |
Travel + Leisure Co
TNL
|
$10.8M |
Sector Composition
| 1 | Healthcare | 44.5% |
| 2 | Consumer Discretionary | 15.38% |
| 3 | Industrials | 7.43% |
| 4 | Financials | 6.27% |
| 5 | Technology | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Elicio Therapeutics
ELTX
$172M
| $839K | 0.05% | 1,033,145 -32,867 | -3% | -$26.7K |
|
77
Daktronics
DAKT
$852M
| $824K | 0.05% | +292,187 | New | +$824K |
|
|
IDW
78
DELISTED
IDW Media Holdings
IDW
| $786K | 0.05% | 836,019 -203,811 | -20% | -$192K |
|
79
SPAR Group
SGRP
$28.2M
| $700K | 0.05% | 538,427 | – | – |
|
80
Neuropace
NPCE
$303M
| $646K | 0.04% | 433,582 -9,920 | -2% | -$14.8K |
|
81
Nautilus Biotechnolgy
NAUT
$85.9M
| $522K | 0.03% | 289,845 -365,493 | -56% | -$658K |
|
|
JBIO
82
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $460K | 0.03% | +15,700 | New | +$460K |
|
83
Hyperfine
HYPR
$97.4M
| $458K | 0.03% | 544,930 | – | – |
|
84
Curis
CRIS
$20.9M
| $438K | 0.03% | 796,241 -2,624,269 | -77% | -$1.44M |
|
85
Journey Medical
DERM
$176M
| $434K | 0.03% | +225,996 | New | +$434K |
|
86
Transact Technologies
TACT
$43.8M
| $415K | 0.03% | 65,738 | – | – |
|
87
Lucid Diagnostics
LUCD
$128M
| $380K | 0.02% | 279,537 -6,895 | -2% | -$9.38K |
|
88
Exagen
XGN
$217M
| $352K | 0.02% | 146,559 -3,976 | -3% | -$9.54K |
|
89
Unicycive Therapeutics
UNCY
$74M
| $350K | 0.02% | 647,416 -63,126 | -9% | -$34.1K |
|
90
Cue Biopharma
CUE
$60M
| $266K | 0.02% | 93,297 | – | – |
|
91
Intellicheck
IDN
$109M
| $249K | 0.02% | 124,594 | – | – |
|
|
BACK
92
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $234K | 0.02% | 1,174,253 -55,412 | -5% | -$11.1K |
|
93
Gyre Therapeutics
GYRE
$703M
| $231K | 0.02% | 438,055 -2,116,680 | -83% | -$1.12M |
|
94
Cytokinetics
CYTK
$4.23B
| $220K | 0.01% | +4,802 | New | +$220K |
|
95
Star Group
SGU
$392M
| $153K | 0.01% | +12,681 | New | +$153K |
|
96
Rafael Holdings
RFL
$51.6M
| $136K | 0.01% | 72,678 | – | – |
|
|
HURA
97
TuHURA Biosciences, Inc. Common Stock
HURA
$135M
| $82K | 0.01% | 11,901 -582,912 | -98% | -$4.02M |
|
|
CYRN
98
DELISTED
CYREN Ltd.
CYRN
| $72K | ﹤0.01% | 116,214 -25,401 | -18% | -$15.7K |
|
|
SFT
99
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $45.6K | ﹤0.01% | 200,000 | – | – |
|
|
TCBPW
100
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
| $21K | ﹤0.01% | 235,294 | – | – |
|